Active Versus Passive Anal Sphincter Training in Patients With Fecal Incontinence

by palligoelme@gmail.com | May 28, 2026 | Clinical Trials

​ Conditions: Fecal Incontinence Interventions: Device: Home-based anal electrical stimulator Sponsors: University Hospital, Martin; Comenius University Recruiting Conditions: Fecal Incontinence Interventions: Device: Home-based anal electrical stimulator Sponsors:...

Oral Health and Systemic Diseases: Survey of General Practitioners

by palligoelme@gmail.com | May 28, 2026 | Clinical Trials

​ Conditions: Periodontal Disease; Diabete Mellitus Interventions: Other: Questionnaire Survey Sponsors: University of Roma La Sapienza Recruiting Conditions: Periodontal Disease; Diabete Mellitus Interventions: Other: Questionnaire Survey Sponsors: University of Roma...

First-in-human Imaging Study of Theranostic Pair [68Ga]Ga-DOTA-STR-17126 and Low-dose [177Lu]Lu-DOTA-STR-17126 in Patients With Advanced or Metastatic Cancer

by palligoelme@gmail.com | May 27, 2026 | Clinical Trials

​ Conditions: Metastatic Breast Cancer; Metastatic Prostate Cancer; GRPR-Targeted Molecular Imaging; Theranostic Radiopharmaceuticals; Cancer; Active Cancer; Theranostic; Radiopharmaceutical Interventions: Drug: [177Lu]Lu-DOTA-STR-17126; Drug: [68Ga]Ga-DOTA-STR-17126...

Effectiveness of a Culturally Adapted Online Education Program (iSupport-Korea) for Family Caregivers of People With Dementia

by palligoelme@gmail.com | May 27, 2026 | Clinical Trials

​ Conditions: Dementia Interventions: Behavioral: iSupport-Korea; Behavioral: Dementia information website Sponsors: Chungnam National University Recruiting Conditions: Dementia Interventions: Behavioral: iSupport-Korea; Behavioral: Dementia information website...

A Clinical Trial of Olutasidenib in Patients With Acute Myeloid Leukemia

by palligoelme@gmail.com | May 27, 2026 | Clinical Trials

​ Conditions: Relapsed or Refractory IDH1 Mutation-Positive Acute Myeloid Leukemia Interventions: Drug: Olutasidenib Sponsors: Kissei Pharmaceutical Co., Ltd. Recruiting Conditions: Relapsed or Refractory IDH1 Mutation-Positive Acute Myeloid Leukemia Interventions:...